CHENNAI: The Chennai-based ABL Bio Technologies Ltd., has launched its new pharmaceutical division 'Invia Health' and introduced new products in three categories diabetes, cardiovascular diseases and gastro-intestinal disorders.
Addressing a press conference here on Wednesday, Chairman and Managing Director of ABL Biotechnologies Ltd., K.O. Isaac, said the launch of this new division was a logical extension of what the company was already doing. It had been developing formulations for the healthcare industry and now it had decided to market its own formulations. Mr. Isaac said the company had so far introduced 400 formulations and its products were being marketed in more than 75 countries. The company was planning to expand its manufacturing facility at Tiruchendur in Tamil Nadu with an investment of Rs. 50 crore.